Durvalumab
Products in Health Canada’s databases that list Durvalumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 1
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 30
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| IMFINZI (50 MG) | 02468816 | Marketed | Astrazeneca Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- IMFINZISeptember 24, 2026 · NOC 38337
- IMFINZIAugust 21, 2026 · NOC 38153
- IMFINZIJuly 3, 2026 · NOC 37832
- IMFINZIFebruary 20, 2026 · NOC 36949
- IMFINZIJanuary 22, 2026 · NOC 36769
- IMFINZIJuly 17, 2025 · NOC 35692
- IMFINZIApril 10, 2025 · NOC 35152
- IMFINZIApril 8, 2025 · NOC 35138
- IMFINZIJanuary 17, 2025 · NOC 34705
- IMFINZIOctober 8, 2024 · NOC 34169
- IMFINZIMay 29, 2024 · NOC 33332
- IMFINZIDecember 27, 2023 · NOC 32426
- IMFINZIOctober 25, 2023 · NOC 31940
- IMFINZIJuly 20, 2023 · NOC 31264
- IMFINZIJuly 7, 2023 · NOC 31155
- IMFINZIApril 21, 2023 · NOC 30552
- IMFINZISeptember 28, 2022 · NOC 29108
- IMFINZISeptember 15, 2022 · NOC 28973
- IMFINZIAugust 18, 2022 · NOC 28802
- IMFINZIApril 4, 2022 · NOC 27911
- IMFINZIFebruary 22, 2022 · NOC 27647
- IMFINZIFebruary 17, 2022 · NOC 27615
- IMFINZIFebruary 8, 2022 · NOC 27555
- IMFINZISeptember 21, 2021 · NOC 26701
- IMFINZIJune 14, 2021 · NOC 26070
- IMFINZIMarch 30, 2021 · NOC 25551
- IMFINZIOctober 1, 2020 · NOC 24358
- IMFINZIAugust 23, 2019 · NOC 22567
- IMFINZIMay 4, 2018 · NOC 20824
- IMFINZINovember 3, 2017 · NOC 20026